Search for Clinical Trial Results
Neovascularization, Pathologic - 25 Studies Found
Status | Study |
Completed |
Study Name: Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) Condition: Corneal Neovascularization Date: 2008-05-19 Interventions: Drug: Ranibizumab 10 Patients will receive treatment (Ranibizumab) |
Recruiting |
Study Name: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2014-10-06 Interventions: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |
Completed |
Study Name: Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization Condition: Corneal Neovascularization Date: 2007-08-06 Interventions: Drug: Bevacizumab (Avastin) Bevacizumab 10mg/mL 1 drop BID x 3 weeks |
Recruiting |
Study Name: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2016-08-21 Interventions: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
Study Name: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization Condition: Idiopathic Choroidal Neovascularization Date: 2016-07-27 Interventions: Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
Study Name: Ranibizumab for Myopic Neovascularization Condition: Myopic Choroidal Neovascularization Date: 2010-11-20 Interventions: Drug: ranibizumab injection Ranibizumab intravitreal injection of 0,5 mg ( 0.05mL) |
Recruiting |
Study Name: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) Condition: Type 3 Choroidal Neovascularization Date: 2014-12-10 Interventions: Drug: Aflibercept |
Completed |
Study Name: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) Condition: Choroidal Neovascularization Date: 2007-08-01 Interventions: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye |
Completed |
Study Name: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization Condition: Choroidal Retinal Neovascularization Date: 2013-12-31 Interventions: Drug: Aflibercept Injection Aflibercept intravitreal injection |
Completed |
Study Name: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen Condition: Choroidal Neovascularisation Date: 2009-12-21 Interventions: Drug: ranibizumab 0.5mg |